James Scopa - Oct 25, 2023 Form 4 Insider Report for Aligos Therapeutics, Inc. (ALGS)

Role
Director
Signature
/s/ Lucinda Y. Quan, as attorney-in fact for James Scopa
Stock symbol
ALGS
Transactions as of
Oct 25, 2023
Transactions value $
$150,000
Form type
4
Date filed
10/27/2023, 04:13 PM
Previous filing
Aug 9, 2023
Next filing
Feb 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALGS Common Stock Award $139K +183K $0.76 183K Oct 25, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALGS Warrant (Right to Buy) Award $11.4K +91.5K $0.13* 91.5K Oct 25, 2023 Common Stock 91.5K $0.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.